Vertex-Crinetics Pharmaceuticals deal receives clearance in Australia
MLex Summary: Vertex Pharmaceuticals’ proposal to acquire Crinetics Pharmaceuticals has received regulatory clearance from Australia’s antitrust watchdog. In a determination published on Thursday, the Australian Competition & Consumer Commission said there...To view the full article, register now.
Already a subscriber? Click here to view full article